Avaleigh Milne is the Global Head of Business Development Strategy & Practice in Pharma Partnering at Roche. Partnerships are a core pillar of how Roche innovates for patients and our partnering activities focus on deals that can complement our broad and diverse portfolio across therapeutic areas and development stages. Avaleigh brings knowledge and experience from a range of business development roles within Roche / Genentech in San Francisco and Basel across multiple therapeutic areas. Prior to Roche, she gained significant industry experience across pharma, venture capital and startups, including at Atlas Venture as a member of their Life Sciences investment team and in Corporate Development at Millennium Pharmaceuticals. She began her career at Bain & Company working with pharma and medtech companies. Avaleigh holds an MBA from Harvard Business School, an MPhil in Bioscience Enterprise from the University of Cambridge, and an AB from Harvard University.